| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXSL1300036 | 血管内皮生长因子抑制剂 | Other | Biological Products | Import Drug Application | 2013-06-03 | Bayer Pharma AG | Bayer Pharma AG | Certificate Issued | 2015-12-10 | view | |
| JXSL1400056 | 阿柏西普眼内注射溶液 | aflibercept | Injection | Biological Products | Import Drug Application | 2014-12-29 | Bayer Pharma AG | Bayer Pharma AG | Certificate Issued | 2016-12-19 | view |
| JXSL1400051 | 阿柏西普眼内注射溶液 | aflibercept | Injection | Biological Products | Import Drug Application | 2014-11-02 | Bayer Pharma AG | Bayer Pharma AG | Certificate Issued | 2016-02-04 | view |
| JYHB1701335 | 硫酸阿米卡星吸入剂(BAY 41-6551) | Amikacin sulfate | Inhalation | Chemical Drugs | Supplementary Application | 2017-10-31 | Bayer Pharma AG | Bayer Pharma AG | Certificate Issued | 2018-03-22 | view |
| JXSL1400050 | 阿柏西普眼内注射溶液 | aflibercept | Injection | Biological Products | Import Drug Application | 2014-11-02 | Bayer Pharma AG | Bayer Pharma AG | Certificate Issued | 2016-02-04 | view |
| JXSL1400049 | 阿柏西普眼内注射溶液 | aflibercept | Injection | Biological Products | Import Drug Application | 2014-11-02 | Bayer Pharma AG | Bayer Pharma AG | Certificate Issued | 2016-02-04 | view |
| JYHB1601721 | 硫酸阿米卡星吸入剂(BAY 41-6551) | Amikacin sulfate | Inhalation | Chemical Drugs | Supplementary Application | 2016-12-30 | Bayer Pharma AG | Bayer Pharma AG | Certificate Issued | 2017-05-08 | view |